Interferon-γ releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants

Infection

Volumn 38, Issue 3, 2010, Pages 195-204

  Orlando, G ^a   Merli, S ^a   Cordier, L ^a   Mazza, F ^a   Casazza, G ^b   Villa, A M ^c   Codecasa, L ^d   Negri, E ^e   Cargnel, A ^f   Ferrarese, M ^d   Rizzardini, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Outpatient Service of Opera San Francesco   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e Parma Hospital   (Italy)

^f Fondazione AIDS Aiuto   (Italy)

Author keywords

Immigrants; Interferon releasing assay; Latent TB infection; TB screening; Tuberculin skin test

Indexed keywords

GAMMA INTERFERON;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMIGRANT; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKIN INDURATION; TUBERCULIN TEST;

ADULT; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; MASS SCREENING; PROSPECTIVE STUDIES; RISK FACTORS; TUBERCULIN TEST;

EID: 77953229776     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-010-0015-2     Document Type: Article

References (43)

1. U Mack GB Migliori M Sester HL Rieder S Ehlers D Goletti A Bossink K Magdorf C Hölscher B Kampmann SM Arend A Detjen G Bothamley JP Zellweger H Milburn R Diel P Ravn F Cobelens PJ Cardona B Kan I Solovic R Duarte DM Cirillo C Lange for the TBNET LTBI 2009 Latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Eur Respir J 33 956 973 10.1183/09031936.00120908 1:CAS:528:DC%2BD1MXmtFahtLk%3D 19407047
2. American Thoracic Society, Centers for Disease Control and Prevention 2000 Diagnostic standards and classification of tuberculosis in adults and children Am J Respir Crit Care Med 161 1376 1395
3. Dick M, Madhukar P, George C. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection-areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354.
4. Royal College of Physicians. Tuberculosis: national clinical guidelines for diagnosis, management, prevention, and control. London: Royal College of Physicians; 2006. http://www.nice.org.uk.
5. L Wang MO Turner RK Elwood M Schulzer JM Fitzgerald 2002 A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements Thorax 57 804 809 10.1136/thorax.57.9.804 1:STN:280: DC%2BD38vktlSntQ%3D%3D 12200526 (Pubitemid 34984980)
6. CDC. Guide for primary health care providers: targeted tuberculin testing and treatment of latent tuberculosis infection. Department of Health and Human Services Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention Division of Tuberculosis Elimination-Atlanta, Georgia 2005.
7. P Andersen ME Munk JM Pollock TM Doherty 2000 Specific immunebased diagnosis of tuberculosis Lancet 356 1099 1104 10.1016/S0140-6736(00)02742-2 1:CAS:528:DC%2BD3cXnsVCktbw%3D 11009160
8. ®-TB gold test for detecting mycobacterium tuberculosis infection, United States Recommendations and Reports December 16. 2005;54:49-55.
9. SM Arend AC Engelhard G Groot K De Boer P Andersen TH Ottenhoff JT Van Dissel 2001 Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact Clin Diagn Lab Immunol 8 1089 1096 1:CAS:528:DC%2BD3MXptVCqsbg%3D 11687445
10. I Brock K Weldingh T Lillebaek F Follmann P Andersen 2004 Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts Am J Respir Crit Care Med 170 65 69 10.1164/rccm.200402-232OC 15087297
11. P Ravn ME Munk AB Andersen B Lundgren JD Lundgren LN Nielsen A Kok-Jensen P Andrsen K Weldingh 2005 Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis Clin Diagn Lab Immunol 12 491 496 1:CAS:528: DC%2BD2MXhtVejsrjI 15817755
12. G Ferrara M Losi M Meacci B Meccugni R Piro P Roversi BM Bergamini R D'Amico P Marchegiano F Rumpianesi LM Fabbri L Richeldi 2005 Routine hospital use of a new commercial whole blood interferon-g assay for the diagnosis of tuberculosis infection Am J Respir Crit Care Med 172 631 635 10.1164/rccm.200502-196OC 15961696 (Pubitemid 41232976)
13. YA Kang HW Lee HI Yoon B Cho SK Han YS Shim JJ Yim 2005 Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country JAMA 293 2756 2761 10.1001/jama.293.22.2756 1:CAS:528:DC%2BD2MXltVCgurY%3D 15941805 (Pubitemid 40965087)
14. T Mori M Sakatani F Yamagishi T Takashima Y Kawabe K Nagao E Shigeto N Harada S Mitarai M Okada K Suzuki Y Inoue K Tsuyuguchi Y Sasaki GH Mazurek I Tsuyuguchi 2004 Specific detection of tuberculosis infection: an interferon-g-based assay using new antigens Am J Respir Crit Care Med 170 59 64 10.1164/rccm.200402-179OC 15059788
15. CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49:1-54.
16. T Tuuminen S Sorva K Liippo T Vasankari H Soini B Eriksén-Neuman A Miettinen IJ Seppälä 2007 Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage Clin Microbiol Infect 13 836 838 10.1111/j.1469-0691.2007.01750.x 1:CAS:528:DC%2BD2sXpslOltLw%3D 17501976 (Pubitemid 47039922)
17. Y Kobashi Y Obase M Fukuda K Yoshida N Miyashita M Fujii 2007 Oka M: Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers Intern Med 46 1543 1549 10.2169/internalmedicine.46.0088 17878640 (Pubitemid 47521049)
18. GH Mazurek SE Weis PK Moonan CL Daley J Bernardo AA Lardizabal RR Reves SR Toney LJ Daniels PA LoBue 2007 Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis Clin Infect Dis 45 837 845 10.1086/521107 1:CAS:528: DC%2BD2sXhtFOntr7O 17806047 (Pubitemid 47580374)
19. YA Kang HW Lee SS Hwang SW Um SK Han YS Shim JJ Yim 2007 Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis Chest 132 959 965 10.1378/chest.06-2805 17505029
20. AK Detjen T Keil S Roll B Hauer H Mauch U Wahn K Magdorf 2007 Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis Clin Infect Dis 45 322 328 10.1086/519266 1:STN:280:DC%2BD2szot1Ogsw%3D%3D 17599309 (Pubitemid 47101028)
21. CS Hirsch Z Toossi C Othieno JL Johnson SK Schwander S Robertson RS Wallis K Edmonds A Okwera R Mugerwa P Peters JJ Ellner 1999 Depressed T-cell interferon-g responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy J Infect Dis 180 2069 2073 10.1086/315114 1:CAS:528:DC%2BD3cXivVSqtQ%3D%3D 10558973
22. GH Mazurek MJ Zajdowicz AL Hankinson DJ Costigan SR Toney JS Rothel LJ Daniels FB Pascual N Shang LW Keep PA LoBue 2007 Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays Clin Infect Dis 45 7 826 836 10.1086/521106 1:CAS:528:DC%2BD2sXhtFOntr7N 17806046 (Pubitemid 47580373)
23. S Jones D de Gijsel FR Wallach AC Gurtman Q Shi H Sacks 2007 Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals Int J Tuberc Lung Dis 11 1190 1195 1:STN:280:DC%2BD2snjsFWhtQ%3D%3D 17958980
24. CZ Grimes LY Hwang ML Williams CM Austin EA Graviss 2007 Tuberculosis infection in drug users: interferon-gamma release assay performance Int J Tuberc Lung Dis 11 1183 1189 1:STN:280:DC%2BD2snjsFWhtA%3D%3D 17958979
25. H Takahashi K Shigehara M Yamamoto C Suzuki Y Naishiro Y Tamura Y Hirohashi N Satoh N Shijubo Y Shinomura K Imai 2007 Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration Rheumatol Int 27 1143 1148 10.1007/s00296-007-0361-2 1:CAS:528:DC%2BD2sXhtVSisLbP 17503048 (Pubitemid 47373944)
26. WP Franken JF Timmermans C Prins EJ Slootman J Dreverman H Bruins JT Van Dissel SM Arend 2007 Comparison of mantoux and QuantiFERON TB gold tests for diagnosis of latent tuberculosis infection in army personnel Clin Vaccine Immunol 14 477 480 10.1128/CVI.00463-06 1:CAS:528:DC%2BD2sXkvVSkt7g%3D 17301213 (Pubitemid 46732561)
27. C Stephan T Wolf U Goetsch, et al. 2008 Comparing QuantiFERON- tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country AIDS 22 2471 2479 10.1097/QAD.0b013e3283188415 19005270
28. WHO: Addressing poverty in TB control options for national TB control programmes. who/htm/tb/2005.352.
29. Carvalho AC, Pezzoli MC, El-Hamad I, Arce P, Bigoni S, Scarcella C, Indelicato AM, Scolari C, Carosi G, Matteelli A. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect. 2007;55:164-8
30. JF Broekmans GB Migliori HL Rieder J Lees P Ruutu R Loddenkemper MC Raviglione 2002 World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group Eur Respir J 19 765 775 10.1183/09031936.02.00261402 1:STN:280:DC%2BD383lvFGktg%3D%3D 11999007 (Pubitemid 34285174)
31. Ministero della Salute: Linee-guida per il controllo della malattia tubercolare, su proposta del Ministro della Sanità, ai sensi dell'art. 115, comma 1, lettera b), del decreto legislativo 31 marzo 1998, n. 112.
32. WHO: DOTS expansion plan to stop TB in the WHO European regions 2002-2006. ISBN 92 890 1367 2, World Health Organization 2002.
33. http://www.ministerosalute.it/imgs/C-17-pubblicazioni-613-allegato.pdf.
34. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177:1164-70
35. A Soysal T Torun S Efe H Gencer K Tahaoglu M Bakir 2008 Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection Int J Tuberc Lung Dis 12 50 56 1:STN:280: DC%2BD1c%2FgvVartg%3D%3D 18173877
36. M Farhat C Greenaway M Pai D Menzies 2006 False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10 1192 1204 1:STN:280:DC%2BD28npsVWksw%3D%3D 17131776
37. WHO: Selected vaccine introduction status into routine immunization. Selected vaccine introduction status into routine infant immunization worldwide, 2003. www.who.int/entity/immunization-monitoring/routine/schedule-analysis- 2003.pdf.
38. Bocchino M, Matarese A, Bellofiore B, Giacomelli P, Santoro G, Balato N, Castiglione F, Scarpa R, Perna F, Signoriello G, Galati D, Ponticiello A, Sanduzzi A. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis. 2008 May 10.
39. Ponce de Leon JD, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M: Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) Infection in Patients with Rheumatoid Arthritis in a TB-Endemic Population. J Rheumatol. 2008 May;35:776-81.
40. Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly KD, LeFevre AM, Ngom Gueye NF, Dieye T, Sow PS, Mboup S, Lienhardt C. Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One. 2008;3:e1441.
41. MX Rangaka KA Wilkinson R Seldon G Van Cutsem GA Meintjes C Morroni P Mouton L Diwakar TG Connell G Maartens RJ Wilkinson 2007 Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection Am J Respir Crit Care Med 175 514 520 10.1164/rccm.200610-1439OC 17158278 (Epub 2006 Dec 7) (Pubitemid 46354256)
42. R Diel A Nienhaus R Loddenkemper 2007 Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany Chest 131 1424 1434 10.1378/chest.06-2728 17494792 (Pubitemid 46762348)
43. A Lalvani 2007 Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy Chest 131 1898 1906 10.1378/chest.06-2471 17565023 (Pubitemid 46981652)